Poor outcomes in patients with cirrhosis and Corona Virus Disease-19
Authors:
- 1 June 2020
- journal article
- research article
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 39 (3) , 285-291
Abstract
Background and Aim There is a paucity of data on the clinical presentations and outcomes of Corona Virus Disease-19 (COVID-19) in patients with underlying liver disease. We aimed to summarize the presentations and outcomes of COVID-19-positive patients and compare with historical controls. Methods Patients with known chronic liver disease who presented with superimposed COVID-19 (n = 28) between 22 April 2020 and 22 June 2020 were studied. Seventy-eight cirrhotic patients without COVID-19 were included as historical controls for comparison. Results A total of 28 COVID-19 patients (two without cirrhosis, one with compensated cirrhosis, sixteen with acute decompensation [AD], and nine with acute-on-chronic liver failure [ACLF]) were included. The etiology of cirrhosis was alcohol (n = 9), non-alcoholic fatty liver disease (n = 2), viral (n = 5), autoimmune hepatitis (n = 4), and cryptogenic cirrhosis (n = 6). The clinical presentations included complications of cirrhosis in 12 (46.2%), respiratory symptoms in 3 (11.5%), and combined complications of cirrhosis and respiratory symptoms in 11 (42.3%) patients. The median hospital stay was 8 (7–12) days. The mortality rate in COVID-19 patients was 42.3% (11/26), as compared with 23.1% (18/78) in the historical controls (p = 0.077). All COVID-19 patients with ACLF (9/9) died compared with 53.3% (16/30) in ACLF of historical controls (p = 0.015). Mortality rate was higher in COVID-19 patients with compensated cirrhosis and AD as compared with historical controls 2/17 (11.8%) vs. 2/48 (4.2%), though not statistically significant (p = 0.278). Requirement of mechanical ventilation independently predicted mortality (hazard ratio 13.68). Both non-cirrhotic patients presented with respiratory symptoms and recovered uneventfully. Conclusion COVID-19 is associated with poor outcomes in patients with cirrhosis, with worst survival rates in ACLF. Mechanical ventilation is associated with a poor outcome.Keywords
This publication has 13 references indexed in Scilit:
- COVID-19: Abnormal liver function testsJournal of Hepatology, 2020
- Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID‐19 PandemicClinical Liver Disease, 2020
- COVID-19 and the liver: little cause for concernThe Lancet Gastroenterology & Hepatology, 2020
- COVID-19: Beyond Respiratory TractJournal of Digestive Endoscopy, 2020
- Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal BleedingDigestive Diseases and Sciences, 2019
- Prevalence, predictors and impact of bacterial infection in acute on chronic liver failure patientsDigestive and Liver Disease, 2018
- Severity and Outcome of Acute-on-Chronic Liver Failure is Dependent on the Etiology of Acute Hepatic InsultsJournal of Clinical Gastroenterology, 2017
- Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCTHepatology International, 2016
- Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of CirrhosisGastroenterology, 2013
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004